Atlas Trials

Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3

Clinical trial NCT07465926 · COMPLETED

Trial details

NCT number
NCT07465926
Sponsor
Chung Shan Medical University
Status
COMPLETED
Study type
OBSERVATIONAL
Cardiovascular-kidney-metabolic SyndromeCardiovascular Disease Risk FactorKidney DiseaseType 2 DiabetesObesity & Overweight
Start date
2017-01-01
Primary completion
2026-01-31
Enrollment
451036

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.